Cindoruk M et al. |
Influence of H pylori on plasma ghrelin in patients without atrophic gastritis. |
2007 |
World J. Gastroenterol. |
pmid:17461454
|
Mesquita MA et al. |
One-week dual therapy with ranitidine bismuth citrate and clarithromycin for the treatment of Helicobacter pylori infection in Brazilian patients with peptic ulcer. |
2005 |
World J. Gastroenterol. |
pmid:15962376
|
Keshavarz AA et al. |
Omeprazole-based triple therapy with low-versus high-dose of clarithromycin plus amoxicillin for H pylori eradication in Iranian population. |
2007 |
World J. Gastroenterol. |
pmid:17352026
|
Hwang JJ et al. |
Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease. |
2015 |
World J. Gastroenterol. |
pmid:25945019
|
Lin LC et al. |
Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials. |
2016 |
World J. Gastroenterol. |
pmid:27340362
|
Miehlke S et al. |
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study). |
2001 |
World J. Gastroenterol. |
pmid:11819768
|
Lee HJ et al. |
Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies. |
2015 |
World J. Gastroenterol. |
pmid:25574111
|
Campuzano-Maya G |
Cure of alopecia areata after eradication of Helicobacter pylori: a new association? |
2011 |
World J. Gastroenterol. |
pmid:21912461
|
Hao Q et al. |
New mutation points in 23S rRNA gene associated with Helicobacter pylori resistance to clarithromycin in northeast China. |
2004 |
World J. Gastroenterol. |
pmid:15052698
|
Sargýn M et al. |
Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori. |
2003 |
World J. Gastroenterol. |
pmid:12717872
|
Lai YC et al. |
Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers. |
2004 |
World J. Gastroenterol. |
pmid:15052680
|
Cianci R et al. |
Third-line rescue therapy for Helicobacter pylori infection. |
2006 |
World J. Gastroenterol. |
pmid:16688818
|
Zhang L et al. |
Eradication of H pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy. |
2006 |
World J. Gastroenterol. |
pmid:16804982
|
Shimbo I et al. |
Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy. |
2005 |
World J. Gastroenterol. |
pmid:16437727
|
Heo J and Jeon SW |
Optimal treatment strategy for Helicobacter pylori: era of antibiotic resistance. |
2014 |
World J. Gastroenterol. |
pmid:24914324
|
Chen KY et al. |
Hybrid vs sequential therapy for eradication of Helicobacter pylori in Taiwan: A prospective randomized trial. |
2015 |
World J. Gastroenterol. |
pmid:26420970
|
Hwang JJ et al. |
Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication. |
2015 |
World J. Gastroenterol. |
pmid:26401089
|
Mohammadi M et al. |
Helicobacter pylori antibiotic resistance in Iran. |
2005 |
World J. Gastroenterol. |
pmid:16273615
|
Garza-González E et al. |
A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication. |
2014 |
World J. Gastroenterol. |
pmid:24587620
|
Farshad S et al. |
Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran. |
2010 |
World J. Gastroenterol. |
pmid:21128326
|